James B. Tananbaum is 10% Owner at AERIE PHARMACEUTICALS INC (AERI). They have made 16 open-market trades across 7 companies since 2016, most recently 2026-08-10.
CIK 0001581754
13 open-market purchases totalling $116.6M since 2019, against 3 sales. Across 12 scored buys the stock is up 41.2% at ninety days, and 36.1 points ahead of the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 62% | 62% | 58% |
| Avg Move | +8.3% | +14.1% | +41.2% |
| Alpha | +7.7% | +13.0% | +36.1% |
| Scored | 13 | 13 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LTGO | BUY | 2026-08-10 | 2026-08-10 | $18.00 | $2.5M | +17.4% | +24.5% | — |
| ALMS | BUY | 2026-01-08 | 2026-01-12 | $17.00 | $7.0M | +17.6% | +22.9% | +8.0% |
| ALMS | BUY | 2025-11-21 | 2025-11-25 | $7.38 | $1.1M | +50.6% | +48.0% | +273.1% |
| ALMS | BUY | 2025-11-17 | 2025-11-19 | $6.11 | $3.8M | +2.2% | +55.7% | +266.6% |
| ALMS | BUY | 2025-05-02 | 2025-05-06 | $4.50 | $202K | +20.1% | -28.4% | -12.6% |
| ALMS | BUY | 2024-07-01 | 2024-07-03 | $16.00 | $40.0M | -9.3% | +6.1% | -12.8% |
| KNTE | BUY | 2023-05-08 | 2023-05-10 | $2.80 | $10.0M | +8.2% | -8.7% | -29.3% |
| PRDS | BUY | 2023-04-05 | 2023-04-06 | $1.50 | $1.2M | +4.3% | +17.2% | +12.9% |
| PRDS | BUY | 2022-12-01 | 2022-12-05 | $0.85 | $542K | -6.5% | +63.7% | +18.5% |
| KNTE | BUY | 2020-12-03 | 2020-12-04 | $20.00 | $20.0M | -14.1% | -12.0% | -29.8% |
| FSDC | BUY | 2020-08-14 | 2020-10-19 | $10.00 | $4.4M | -3.9% | -3.5% | +19.8% |
| AERI | BUY | 2019-08-30 | 2019-09-04 | $21.00 | $1.6M | +28.5% | +7.2% | +2.9% |
| AERI | BUY | 2019-08-12 | 2019-08-14 | $24.83 | $24.3M | -6.9% | -10.1% | -23.1% |
| AERI | SELL | 2017-05-26 | 2017-05-31 | $55.95 | $2.2M | -8.2% | -5.3% | -0.7% |
| AERI | SELL | 2016-10-06 | 2016-10-11 | $40.34 | $4.0M | -9.9% | -6.1% | -0.2% |
| AIMT | SELL | 2016-05-31 | 2016-06-02 | $15.23 | $1.8M | -17.1% | -31.5% | -3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| FSDC | 441,500 | $5.6M |
| ACRS | 8,276 | $27K |
| QSI | 20,512 | $23K |
| Total | $177.8M |
Shares reported on the most recent Form 4, priced at the 2026-08-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.